Document is current
Any future updates will be listed below
-
Authors
Zhao, Feiyan https://orcid.org/0000-0002-7360-5436
Guo, Zhenguo
Kwok, Lai-Yu
Zhao, Zhixin
Wang, Kexin
Li, Yalin
Sun, Zhihong
Zhao, Jianmin
Zhang, Heping
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr1800019268 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
Bifidobacterium lactis Probio-M8 improves bone metabolism in patients with postmenopausal osteoporosis, possibly by modulating the gut microbiota
https://doi.org/10.1007/s00394-022-03042-3
-
Funding
Funding for this research was provided by:
Inner Mongolia Science and Technology Major Projects (2021ZD0014)
the Earmarked Fund for CARS-36
- License Information
-
More Information
Article History
Received: 10 June 2022
Accepted: 20 October 2022
First Online: 5 November 2022
Declarations
:
: The authors declare no competing interests.
: This intervention trial was approved by Ethics Committee of the Affiliated Hospital of Inner Mongolia Medical University (project number KY 2018010) and registered in the Chinese Clinical Trial Registry (; identifier number: ChiCTR1800019268). An informed consent was signed by all subjects prior to the study.
: Not applicable.
